Dr. Mina is the Chief Science Officer of eMed, where he leads the Advisory Services group in enabling diagnostics companies to digitize their point of care solutions on the eMed platform. Additionally Dr. Mina drives eMed’s Clinical Trial Recruitment services and supports in development and execution of go-to-market strategies for the company’s new services, including Test-to-Treat™.
Dr. Mina joins eMed from Harvard T.H. Chan School of Public Health, where he was Associate Professor of epidemiology, immunology and infectious diseases, as well as a core faculty member of the Center for Communicable Disease Dynamics (CDCC). Dr. Mina earned his Ph.D. and M.D. from Emory University and performed postdoctoral research at Princeton University and Harvard Medical School.
